Response to Letter to the Editor: Implications of Clinical and Genetic Management of Subjects With BAP1 Germline Variants.
| Publicado en: | Journal of Thoracic Oncology Vol. 21; no. 9 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196192927&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 196192927 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15560864 4Z2B jtl: Journal of Thoracic Oncology issn: 15560864 maglogo: N pubinfo: dt: Sep2026 vid: 21 iid: 9 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 196192927 10.1016/j.jtho.2026.103959 196192927 ppct: 1 formats: tig: atl: Response to Letter to the Editor: Implications of Clinical and Genetic Management of Subjects With BAP1 Germline Variants. aug: au: Wu, Xinwei Wang, Haitao Wang, Ruihong Schrump, David S. Lebensohn, Alexandra Carbone, Michele Hassan, Raffit affil: Thoracic Surgery Branch, National Cancer Institute, Bethesda, Maryland sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|